B1-995) Ih

J.A.,
a 6 y e a r -o l d g i r l with small g o i t r e had e l e v a t e d l e v e l s o f T4, T 3 a s well cis TSH. Her high and w e i e h t were a t t h e 10th p e r c e n t i l e , bone age was delayed a b o u t 2 y e a r s but c l i n i c a l l y she was eutilyroid. Treatment w i t h t,h. r e s u l t e d i n T8H suppresion but s i n g s o f hyperthyroidism appeared. During t h e n e x t 3 y e a r s without any t r e a t m e n t T4, T 3 and bass1 TSH were s t i l l e l e v a t e d and TRH s t i m u l a t e d TSh i n c r e a s e d t o t h e hypothyroid range. A t t h e age o f 9 y e a r s c l i n i c a l symptams of hyperthyroidism were e v i d e n t , Hypothalamo-pituitary s t u d i e s were normal, t h e r e was no evidence f o r n i t u i t a r v tumor. A a r t i s s e l e c t i v e i t u i t a r y r e s i s t a n c e t o t h, wass u E p o s e d ,~i n c e 19SOPthe p a t i e n t~~-%~~~4 i n a dose o f 0.5mdd. Grsdual d e c r e a s e o f TSH l e v e l s was accompanied by r e d u c t i o n i n t h e s i z e of g o i t r e and a m e l i o r a t i o n o f c l i n i c a l symptoms o f hyperthyroidism, confirmed by n o r m a l i s a t i o n of WR, Temporary i n t e r r u pt i o n o f D-T4 t h e r a p y r e s u l t e d i n t h e i n c r e a s e o f a l l c l i n i c a l and biochemical a b a o r m a l i t i e s . To our know-SMS 201-995 was used In a 4 month-old boy presenting hypoglycemic seizures with hyperinsulinism. The dose of SMS 201-995 was rapidly increased during the first week from 10 ug/kg/day to 100 ug/kg/day, and was administrated using continuous subcutaneous infusion (CS1) durlng 8 months and then 3 or 2 dally subcutaneous infusion per day for 1 month. Capillary blood glucose was measured every 3 hours. Plasma insulln was evaluated twice dally on the first weeks and when blood glucose was lower than 50 mg/dl. Mean blood glucose levels was dramatically and rapidly increased by therapy, frequency of hypoglycemia was strongly reduced, blood glucose/insulin ratio ~ncreased,carbohydrate needs were reduced (O.Gg/kg/day). CT Scan of the pancreas performcd before therapy not~ced a global increase ~f the volume of the gland which was no more observed after one month of therapy. Growth velocity remained In a normal range l'or age. Measure of plasma GH every 20 min durlng 5 hours had shown a normal spontaneous GI1 peak of 50 ng/ml. Neurologic development was normal. Others endocrlrr:'unctlons remalned normal. 'Tolerance of thls treatment was good excepted for translent dlarrllea and vomiting during the flrst 2 weeks of therapy and translent moderate Increase of Gamma GT. Treatment had been interrupted after one and 6 months of therapy with reccurrent hypoglycemia after 3 and 6 days resoectlvelv. 3 or 2 subcutaneous inieci-ions resulted In a worstlv
l i d g e t h i s i s t h e f i , -s t case o f h e r t h roidism due t o
zlycem~c control than CSI therapy. DUE TO FOCAL ADENOMATOSIS OF TllE PANCREAS Whilst the last 10 years'literature unaninously points out the increased prevalence of serua HCllA in children and youngsters uilh insulin-dependent dialietcs nellitus (IOUH), the predictive value of overt thyroid disease or such a biohumoral n a r k c r in these patients widely varies according to the different Authars:Frcqucntly>40% in US reports, generally <lo% in Curopean reports. We falloued for a 5-yr period 12 HCllA positive IOUH children (12/99 v s a prcvalcncc of 61191 Found in an age-mat ched control group. X2=9.5. p(0.005).
who underwent semestral clir~ical and biochemical (14, 13, r74, FT3, TSII, IS11 response to i.v. 1RII) assessments OF thyroid function. w: a ) during the wllole follou-up period. the HCllA titers llave been fluctuating up and down in all patients. uilli no effects on tl~yroid iunction tcsls; b ) no patient has been shouing goiter o r olher clinical signs of thyroid dysfunclion; c ) no patient has b e c n exhibiting pcrsistcnl or even transient changes in thyroid function Lcsts suggestive or hypothyroidism o r Ihypertltyroidism; d) in 4/12 c a ses the first Tnll-lest elicited a TSll liyperrespor~se suggeslivc or subclinical hyp! Lhyroidisn, but sucl, a pattern was not confirmed at Lllc ncxl tests. Conclusions: based on a longitudinal study, o u r data confirm that the increased prevalence of HCllA in IDOH children is not associated to high risk of overt thyde report the use of somatostatin in a newborn infant with hyperinsulinism due to focal adenomatosis of the pancreas. When administred alone at a rate of 2,5 to 7 u/kg/h, tlle natural somatostatin was documented to be short-(imed able to prevent hypoglycemia. However the association to glucagon infusion at a rate of 2,5 /u/kg/h allowed successful control of patient's hypoglycemia. As hyperinsulinism relapsed a'Tter a subtotal pancreatectomy, a trial with somatostatin analogue SMS 201-995, which has an expected longer duration of action was performed. It lead to a significant rjse in the blood glucose level but failed to prevent safely hypoglycemia even when four injections were performe~l So, three hours after a subcutaneous injection of 10 ug of thc analogue, the blood glucose concentration raised sign(ficantly to 5 -7 mmol./l., but after four to five hours, the level dropped again to 1 , 8 -2,2 mmol./l.. The young agc of the infant and the cerebral risk of hypoglycemia did not allow us to increase posology and injection's frequency ; then a near total pancreatectomy was performed.
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CONTINUOUS SUBCUTANEOUS GLUCAGON INFUSION IS AN 184
HYPERINSULINEMIC HYPOGLYCEMIA (NESIDIOBLASTOSIS?) .
EFFECTIVE MEAN OF INCREASING BLOOD GLUCOSE (BG) IN OUTCOME OF 7 CASES TREATED WITH LOW LEUCINE DIET AND fNPERINSULINEMIC INFANTS.
DIAZOXIDE.
fIyperinsulinemic infants develop severe hypoglycemia due to a Mental subnormality in hyperinsulinemic hypoglycemia major suppression of glucose production by the liver. ~~~~t~~~~t (14H) of infancy, in the reported series, ranges from 35 to 60%. we of this condition is made difficult in a subset of patients by report on the outcome of 7 cases. All but one presented with the limited efficacy o f drugs, such as diazoxide or corticoste.
C O~V U~S L O~S prior to the age of 9 months. The diagnosis of HH roids. The need for mairltaining a large supply of glucose in the.
was based on low glucose-insulin ratlo (G/I) in random blood were indicative but not diagnostic of AH while post I> G/I values propose that the subcutaneous continuous infusion of glucagon established the diagnosis. Strict adherence to diet combined with should be largely employed for the control of hypoglycemia in indiazoxide gave the best results and llmited the need for pancreafants developing severe hyperinsulinism and/or resistance to diatectomy. Either.diet or diazoxide alone proved ineffective. zoxide therapy.
